{
  "id": 16218025,
  "title": "Q&A: Bristol Myers' Lynelle Hoch on autoimmune CAR-T safety challenges",
  "url": "https://urgent.news/2026/10/23/q-a-bristol-myers-lynelle-hoch-on-autoimmune-car-t-safety-challenges",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-23T18:36:40.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/qa-bristol-myers-lynelle-hoch-on-autoimmune-car-t-safety-challenges/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Bristol Myers Squibb is facing one problem after another with its autoimmune CAR-T therapy program. The company says it has figured out the cause of the safety signal in a lupus trial ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "STAT News",
        "title": "STAT+: Patient dies in Bristol Myers Squibb autoimmune CAR-T trial",
        "url": "https://urgent.news/2026/10/23/stat-patient-dies-in-bristol-myers-squibb-autoimmune-car-t-trial",
        "published": "2026-10-23T18:55:12.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}